Studies on metals in motor neuron disease
Author: Roos, Per M
Date: 2013-03-08
Location: Bergendorffssalen, Nobels väg 13, Karolinska Institutet, Solna
Time: 09.30
Department: Institutet för miljömedicin / Institute of Environmental Medicine
Abstract
A slow but steady increase in neurodegenerative disorders has been noted in recent decades. Degenerations in the nervous system are found in Alzheimer's disease, Parkinson's disease and motor neuron diseases. Amyotrophic lateral sclerosis (ALS) is the most common of the motor neuron diseases. It is often considered a model disorder of neurodegeneration. Early symptoms of ALS are limb weakness or weakness in muscles of speech and swallowing. Muscle atrophy follow and a slowly progressing paralysis spreads to respiratory muscles invariably leading to death in respiratory failure. Neurophysiological investigations are necessary for proper diagnosis, and it is important to rule out treatable diagnostic alternatives such as myopathies or polyneuropathies.
The cause of ALS is unknown. Prevailing theories include genetic, viral, inflammatory, oxidative or toxic mechanisms. Some indications point toward metallotoxic etiologies. Clusters of ALS have been observed in regions where geological conditions cause elevated metal concentrations in water and soil. Several studies show increased frequency of ALS in certain occupations. ALS-like conditions are found in animals, notably in horses, where metal exposure can be suspected. In addition animal metal exposure experiments show accumulations of metals in the spinal cord.
The aim of this thesis project is to clarify the role of metals in ALS. The hypothesis tested is that neurotoxic metals contribute significantly to the pathogenesis of ALS. To study this we have measured concentrations of 22 metals in cerebrospinal fluid (CSF) and plasma from patients with ALS and from controls, and correlated findings to literature data to suggest a model for ALS pathogenesis.
Increased concentrations were found for the metals manganese, aluminum, cadmium, cobalt, copper, zinc, lead, vanadium and uranium in CSF from patients with ALS compared to controls. Manganese showed the most prominent correlation. Simultaneous sampling from plasma did not show these elevated concentrations, indicating metal accumulations in ALS CSF. Most of the metals detected in CSF from ALS patients are neurotoxicants.
Studies of mercury distribution in a monkey showed mercury accumulations in the spinal cord after respiratory exposure to mercury. Motor neurons of the spinal cord seem to be more vulnerable to metal toxicity then surrounding cells, as they lack protection from the metal-binding protein metallothionein. Patient exposure to metals, distribution by the bloodstream, penetration of protective barriers and direct toxic effects on neurons of the spinal cord is suggested to be causative in ALS.
It is concluded that neurotoxic metals can reach and affect the anterior horn cells of motor neurons and thereby contribute to the pathogenesis of ALS.
The cause of ALS is unknown. Prevailing theories include genetic, viral, inflammatory, oxidative or toxic mechanisms. Some indications point toward metallotoxic etiologies. Clusters of ALS have been observed in regions where geological conditions cause elevated metal concentrations in water and soil. Several studies show increased frequency of ALS in certain occupations. ALS-like conditions are found in animals, notably in horses, where metal exposure can be suspected. In addition animal metal exposure experiments show accumulations of metals in the spinal cord.
The aim of this thesis project is to clarify the role of metals in ALS. The hypothesis tested is that neurotoxic metals contribute significantly to the pathogenesis of ALS. To study this we have measured concentrations of 22 metals in cerebrospinal fluid (CSF) and plasma from patients with ALS and from controls, and correlated findings to literature data to suggest a model for ALS pathogenesis.
Increased concentrations were found for the metals manganese, aluminum, cadmium, cobalt, copper, zinc, lead, vanadium and uranium in CSF from patients with ALS compared to controls. Manganese showed the most prominent correlation. Simultaneous sampling from plasma did not show these elevated concentrations, indicating metal accumulations in ALS CSF. Most of the metals detected in CSF from ALS patients are neurotoxicants.
Studies of mercury distribution in a monkey showed mercury accumulations in the spinal cord after respiratory exposure to mercury. Motor neurons of the spinal cord seem to be more vulnerable to metal toxicity then surrounding cells, as they lack protection from the metal-binding protein metallothionein. Patient exposure to metals, distribution by the bloodstream, penetration of protective barriers and direct toxic effects on neurons of the spinal cord is suggested to be causative in ALS.
It is concluded that neurotoxic metals can reach and affect the anterior horn cells of motor neurons and thereby contribute to the pathogenesis of ALS.
List of papers:
I. Holmøy T., Bjørgo K., Roos Per M. Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation. European Neurology. Letter to the Editor. 2007. 490, 58: 57-58.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Holmoy T, Roos Per M, Kvale O. Amyotrophic lateral sclerosis: cytokine profile of cerebrospinal fluid T cell clones. Amyotrophic lateral sclerosis and other motor neuron diseases. 2006.7:183-186.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Roos Per M., Dencker L. Mercury in the spinal cord after inhalation of mercury. Basic & Clinical Pharmacology & Toxicology. 2012. Aug;111(2):126-132.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Gellein K., Roos Per M., Evje L., Vesterberg O., Flaten T. P., Nordberg M., Syversen T. Separation of proteins in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Research. 2007. Oct;1174 (12):136-142.
Fulltext (DOI)
Pubmed
View record in Web of Science®
V. Roos Per M., Lierhagen S., Flaten TP., Syversen T., Vesterberg O., Nordberg M. Manganese in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Experimental Biology and Medicine (Maywood). 2012 Jul 1,237(7):803-810.
Fulltext (DOI)
Pubmed
View record in Web of Science®
VI. Roos Per M., Vesterberg O., Syversen T., Flaten TP., Nordberg M. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biological Trace Element Research. 2013. Feb;151(2):159-170.
Fulltext (DOI)
Pubmed
I. Holmøy T., Bjørgo K., Roos Per M. Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation. European Neurology. Letter to the Editor. 2007. 490, 58: 57-58.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Holmoy T, Roos Per M, Kvale O. Amyotrophic lateral sclerosis: cytokine profile of cerebrospinal fluid T cell clones. Amyotrophic lateral sclerosis and other motor neuron diseases. 2006.7:183-186.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Roos Per M., Dencker L. Mercury in the spinal cord after inhalation of mercury. Basic & Clinical Pharmacology & Toxicology. 2012. Aug;111(2):126-132.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Gellein K., Roos Per M., Evje L., Vesterberg O., Flaten T. P., Nordberg M., Syversen T. Separation of proteins in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Research. 2007. Oct;1174 (12):136-142.
Fulltext (DOI)
Pubmed
View record in Web of Science®
V. Roos Per M., Lierhagen S., Flaten TP., Syversen T., Vesterberg O., Nordberg M. Manganese in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Experimental Biology and Medicine (Maywood). 2012 Jul 1,237(7):803-810.
Fulltext (DOI)
Pubmed
View record in Web of Science®
VI. Roos Per M., Vesterberg O., Syversen T., Flaten TP., Nordberg M. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biological Trace Element Research. 2013. Feb;151(2):159-170.
Fulltext (DOI)
Pubmed
Institution: Karolinska Institutet
Supervisor: Håkansson, Helen
Issue date: 2013-02-13
Rights:
Publication year: 2013
ISBN: 978-91-7549-046-5
Statistics
Total Visits
Views | |
---|---|
Studies ...(legacy) | 5251 |
Studies ... | 953 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Studies ... | 15 | 21 | 18 | 4 | 25 | 10 | 10 |
File Visits
Views | |
---|---|
Thesis_Per_Roos.pdf(legacy) | 1411 |
Spikblad_Per_Roos.pdf(legacy) | 759 |
Thesis_Per_Roos.pdf | 708 |
Spikblad_Per_Roos.pdf | 127 |
Thesis_Per_Roos.pdf.txt(legacy) | 2 |
Spikblad_Per_Roos.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 1513 |
Denmark | 1382 |
Sweden | 828 |
Norway | 170 |
United Kingdom | 161 |
Germany | 154 |
Australia | 99 |
China | 95 |
India | 81 |
Ireland | 67 |
Top cities views
Views | |
---|---|
Stockholm | 225 |
Copenhagen | 141 |
Oslo | 139 |
Los Angeles | 89 |
Ashburn | 88 |
Sunnyvale | 85 |
Seattle | 76 |
Romeo | 63 |
Bromma | 55 |
Odense | 54 |